Back to search

Belgium· BE-AMP-SAM115324-00

Dantrium IV 20 mg

A dantrolene product containing dantrolene sodium, registered in Belgium by Norgine. The same ATC class is registered in 16 of our 19 countries.

ATC M03CA01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDantrium IV 20 mgATCM03CA01REGISTER NO.BE-AMP-SAM115324-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Dantrolene is registered in 16 of 19 countries.

Countries holding a registration under ATC M03CA01 (dantrolene), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Dantrolene · ATC M03CA01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dantrolene costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $1.64 in United States to $5.92 in Finland — a ×3.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Dantrolene · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • FI Finland$5.92
  • US United States$1.64 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dantrolene Sodium
Manufacturer
Norgine
Country
Belgium (BE)
ATC code
M03CA01
ATC class
Dantrolene
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0036871
  • be_apb
    2930154

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

93 interactions on record for dantrolene.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dantrolene · interactions on record

93 records

  • 16 severe
  • 60 moderate
  • 17 info

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dantrolene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dantrolene products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Germany · Dantamacrin, Dantrolen I.V.
  • France · Dantrium, Dantrium Intraveineux
  • United Kingdom (Northern Ireland) · Agilus, ​dantrium
  • Ireland · Dantrium
  • Iceland · Agilus
  • Italy · Dantrium
  • Liechtenstein · Agilus
  • Netherlands · Dantrium
  • Norway · Agilus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8a517ce-077e-459e-8569-10a8e23fe48c
GET /v1/drugs/e8a517ce-077e-459e-8569-10a8e23fe48c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Dantrium IV 20 mg",
  "name_fr": "Dantrium IV 20 mg",
  "name_nl": "Dantrium IV 20 mg",
  "amp_code": "SAM115324-00",
  "strengths": [
    "20.0000",
    "3000.0000",
    "0.8000"
  ],
  "pack_count": 2,
  "substances": [
    "Dantrolene Sodium",
    "Mannitol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dantrolene",
  "authorisation_numbers": [
    "BE115324"
  ]
}

See everything about dantrolene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.